-+ 0.00%
-+ 0.00%
-+ 0.00%

Veraxa Biotech CEO Christoph Antz reports purchase of 5,000 shares for $7,650

PUBT·08/31/2026 20:10:55
Listen to the news
Veraxa Biotech CEO Christoph Antz reports purchase of 5,000 shares for $7,650
  • Veraxa Biotech CEO, director Christoph Rudiger Antz reported a purchase of 5,000 ordinary shares.
  • The shares were bought at USD 1.53 each.
  • His direct holding rose to 5,000 ordinary shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veraxa Biotech AG published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001829126-26-009543), on August 31, 2026, and is solely responsible for the information contained therein.